A

Agilent Technologies
D

A

147.350
USD
2.62
(1.81%)
Market Closed
Volume
101,250
EPS
6
Div Yield
0.65
P/E
33
Market Cap
42,082,467,750
Related Instruments
    AAPL
    AAPL
    1.720
    (0.75%)
    229.970 USD
    AMZN
    AMZN
    5.310
    (2.41%)
    225.950 USD
    GOOGL
    GOOGL
    3.080
    (1.60%)
    195.990 USD
    JNJ
    JNJ
    -0.740
    (-0.50%)
    147.060 USD
    JPM
    JPM
    5.06
    (1.99%)
    259.37 USD
    MSFT
    MSFT
    4.37
    (1.03%)
    429.01 USD
    TSLA
    TSLA
    12.93
    (3.13%)
    426.48 USD
    V
    V
    2.48
    (0.78%)
    319.69 USD
    WMT
    WMT
    0.590
    (0.65%)
    91.920 USD
    More
News

Title: Agilent Technologies

Sector: Healthcare
Industry: Diagnostics & Research
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.